Protein Characterization and Identification Market

Protein Characterization and Identification Market Forecast and Outlook 2025 to 2035

The protein characterization and identification industry stands at the threshold of a decade-long expansion trajectory that promises to reshape analytical science and bioanalytical technology. The market's journey from USD 18.5 billion in 2025 to USD 42.8 billion by 2035 represents substantial growth, the market will rise at a CAGR of 8.7% demonstrating the accelerating adoption of advanced protein analysis systems and research technologies across pharmaceutical companies, biotechnology firms, and academic research institutions worldwide.

The first half of the decade (2025-2030) will witness the market climbing from USD 18.5 billion to approximately USD 27.8 billion, adding USD 9.3 billion in value, which constitutes 38.2% of the total forecast growth period. This phase will be characterized by the rapid adoption of mass spectrometry instruments, driven by increasing drug discovery programs and protein analysis automation worldwide. Advanced analytical capabilities and integrated data management features will become standard expectations rather than premium options.

The latter half (2030-2035) will witness sustained growth from USD 27.8 billion to USD 42.8 billion, representing an addition of USD 15.0 billion or 61.8% of the decade's expansion. This period will be defined by mass market penetration of comprehensive analytical platforms, integration with bioinformatics systems, and seamless compatibility with existing laboratory infrastructure. The market trajectory signals fundamental shifts in how research organizations approach protein analysis and characterization, with participants positioned to benefit from sustained demand across multiple research segments.

Quick Stats for Protein Characterization and Identification Market

• Protein Characterization and Identification Market Value (2025): USD 18.5 billion
• Protein Characterization and Identification Market Forecast Value (2035): USD 42.8 billion
• Protein Characterization and Identification Market Forecast CAGR: 8.7%
• Leading Product in Protein Characterization and Identification Market: Instruments
• Key Growth Regions in Protein Characterization and Identification Market: North America, Europe, and Asia Pacific
• Top Key Players in Protein Characterization and Identification Market: Thermo Fisher Scientific, Agilent Technologies, Waters Corporation, Bruker Corporation, Bio-Rad Laboratories

Protein Characterization and Identification Market Year-over-Year Forecast 2025 to 2035

The Protein Characterization and Identification market demonstrates distinct growth phases with varying market characteristics and competitive dynamics. Between 2025 and 2030, the market progresses through its analytical technology adoption phase, expanding from USD 18.5 billion to USD 27.8 billion with steady annual increments averaging 8.5% growth. This period showcases the transition from traditional protein analysis methods to advanced analytical platforms with enhanced precision capabilities and integrated research workflow systems becoming mainstream features.

The 2025-2030 phase adds USD 9.3 billion to market value, representing 38.2% of total decade expansion. Market maturation factors include standardization of protein analysis protocols, declining instrument costs for analytical systems, and increasing research organization awareness of automated protein characterization benefits, reaching 90-94% accuracy in analytical applications. Competitive landscape evolution during this period features established analytical instrument companies like Thermo Fisher Scientific and Agilent Technologies expanding their protein analysis portfolios while new entrants focus on specialized mass spectrometry algorithms and enhanced integration capabilities.

From 2030 to 2035, market dynamics shift toward advanced integration and multi-platform deployment, with growth accelerating from USD 27.8 billion to USD 42.8 billion, adding USD 15.0 billion or 61.8% of total expansion. This phase transition logic centers on comprehensive analytical platforms, integration with bioinformatics systems, and deployment across diverse research specialties, becoming standard rather than specialized applications. The competitive environment matures with focus shifting from basic analytical capability to comprehensive research ecosystems and integration with automated data analysis and laboratory management platforms.

Protein Characterization and Identification Market Key Takeaways

At-a-Glance Metrics

Metric	Value
$ Market Value (2025) →	USD 18.5 billion
$ Market Forecast (2035) ↑	USD 42.8 billion
# Growth Rate ★	8.7% CAGR
Leading Product →	Instruments
Primary End User →	Pharmaceutical Companies

The market demonstrates strong fundamentals with Instruments capturing a dominant share through advanced analytical features and comprehensive research capabilities. Pharmaceutical Companies applications drive primary demand, supported by increasing drug development spending on protein analysis tools and research enhancement systems. Geographic expansion remains concentrated in developed markets with established research infrastructure, while emerging economies show accelerating adoption rates driven by biotechnology growth and rising research automation budgets.

Why is the Protein Characterization and Identification Market Growing?

Drug discovery acceleration demand creates compelling research advantages through protein characterization systems that provide consistent analytical results without manual dependency risks, enabling research organizations to maintain data quality while achieving analytical superiority and reducing analysis costs.

Biotechnology advancement programs accelerate as pharmaceutical companies worldwide seek advanced analytical systems that complement traditional research methods, enabling precise protein identification and characterization applications that align with regulatory standards and research requirements.

Research infrastructure enhancement drives adoption from pharmaceutical operators and biotechnology companies requiring effective analytical tools that minimize data errors while maintaining research quality during complex drug development procedures and compound analysis.

However, growth faces headwinds from capital investment challenges that vary across organizations regarding the deployment of protein characterization systems and research budget protocols, which may limit operational flexibility in certain research environments. Technical limitations also persist regarding system adaptability and integration complexity that may reduce system performance with legacy laboratory equipment or non-standardized analytical formats that limit characterization capabilities.

Opportunity Pathways - Protein Characterization and Identification Market

The protein characterization and identification market represents a transformative growth opportunity, expanding from USD 18.5 billion in 2025 to USD 42.8 billion by 2035 at an 8.7% CAGR. As research systems worldwide prioritize analytical precision, research automation, and drug development, protein characterization systems have evolved from optional equipment to mission-critical infrastructure, enabling consistent analytical results, reducing research costs, and supporting research excellence across pharmaceutical, biotechnology, and academic research applications.

The convergence of drug development mandates, increasing regulatory compliance requirements, analytical technology maturation, and regulatory acceptance of automated systems creates unprecedented adoption momentum. Advanced protein analysis algorithms offering superior precision, seamless research integration, and regulatory compliance will capture premium market positioning, while geographic expansion into emerging research markets and scalable system deployment will drive volume leadership. Government research modernization programs and analytical standardization provide structural support.

• Pathway A - Instruments Dominance: Leading with 60.0% market share through superior analytical precision, cost-effectiveness, and high throughput capabilities, instrument solutions enable comprehensive protein characterization across diverse research settings without significant infrastructure modifications. Advanced features, including automated sample processing, data analysis systems, and seamless integration with laboratory operations, command premium pricing while reducing total research costs. Expected revenue pool: USD 24.2-27.8 billion.
• Pathway B - Pharmaceutical Companies Leadership: Dominating with 45.0% market share, pharmaceutical applications drive primary demand through protein analysis for drug discovery, development programs, and regulatory compliance operations. Specialized systems for compound analysis, drug development, and quality control that exceed regulatory standards while maintaining analytical efficiency capture significant premiums from pharmaceutical operators and drug development authorities. Opportunity: USD 18.5-21.4 billion.
• Pathway C - Regional Market Acceleration: United States (10.2% CAGR) and Germany (9.6% CAGR) lead global growth through aggressive research modernization programs, government funding initiatives, and pharmaceutical infrastructure development. Local partnerships enabling compliance with domestic research regulations, analytical standards, and cost-effective solutions tailored for regional market price points capture expanding demand. Geographic expansion upside: USD 14.8-19.2 billion.
• Pathway D - Mass Spectrometry & Advanced Technology Applications: Beyond traditional analytical instruments, protein characterization applications in mass spectrometry, chromatography, and electrophoresis represent high-growth segments. Advanced analytical systems for complex protein analysis, research applications, and specialized characterization that improve accuracy while ensuring research effectiveness create differentiated value propositions with premium pricing potential. Revenue opportunity: USD 12.4-16.8 billion.
• Pathway E - Technology Integration & Bioinformatics: Research automation acceleration drives demand for smart protein characterization systems, enabling predictive analysis, AI-powered data processing, and automated research workflows. Advanced solutions supporting Research 4.0, real-time monitoring, and predictive analytics expand addressable markets beyond traditional analytical applications. Technology advancement pool: USD 9.8-13.2 billion.
• Pathway F - Reagents & Software Solutions: Growing demand for analytical reagents enabling flexible deployment across multiple research applications, software platforms, and specialized analytical scenarios. Reagent and software solutions supporting operational flexibility, reduced instrument requirements, and multi-application deployment create new market opportunities with moderate premium potential. Solutions opportunity: USD 7.2-10.4 billion.
• Pathway G - Academic & Biotechnology Applications: Increasing research funding drives demand for comprehensive protein characterization systems with academic research, biotechnology applications, and university laboratory capabilities. Academic-focused solutions supporting research goals, grant compliance, and operational cost optimization expand addressable markets with educational premium positioning. Academic solutions pool: USD 5.8-8.6 billion.

Segmental Analysis

The market segments by product into Instruments, Reagents, and Software categories, representing the evolution from traditional instrument solutions to comprehensive analytical systems for complete research coverage.

Technology segmentation divides the market into Mass Spectrometry, Chromatography, Electrophoresis, and Others sectors, reflecting distinct requirements for pharmaceutical research, biotechnology applications, academic studies, and specialized analytical applications.

End user segmentation covers Pharmaceutical Companies, Academic Research, and Biotechnology categories, with developed markets leading adoption while emerging economies show accelerating growth patterns driven by research modernization programs.

The segmentation structure reveals technology progression from traditional single-instrument analytical systems toward integrated research platforms with enhanced precision and data management capabilities, while application diversity spans from pharmaceutical research to comprehensive academic solutions requiring precise automated assistance.

By Product, the Instruments Segment Accounts for Dominant Market Share

Instruments command the leading position in the protein characterization and identification market with approximately 60.0% market share through advanced analytical features, including high precision analysis, consistent performance, and comprehensive characterization capabilities that enable research organizations to deploy protein analysis across diverse laboratory environments without significant operational modifications.

The segment benefits from research organization preference for high-capacity analytical systems that provide reliable characterization results without requiring extensive reagent infrastructure or specialized maintenance protocols. Instrument design features enable deployment in major pharmaceutical facilities, biotechnology companies, and high-throughput operations where analytical consistency and precision represent critical research requirements.

Instrument systems differentiate through established analytical precision, proven characterization capabilities, and integration with existing laboratory workflows that enhance research effectiveness while maintaining cost-effective operational profiles suitable for research organizations of all sizes.

Key market characteristics:

• Advanced analytical algorithms with established characterization capabilities and validated performance parameters
• High-throughput resources enabling comprehensive protein analysis and consistent research outcomes
• Integration capabilities with laboratory management systems, data platforms, and operational monitoring systems for comprehensive analytical workflows

By End User, the Pharmaceutical Companies Segment Accounts for the Largest Market Share

Pharmaceutical companies dominate the protein characterization and identification market by end user with approximately 45.0% market share due to widespread adoption of protein analysis systems and increasing focus on drug discovery, compound development, and regulatory compliance applications that optimize pharmaceutical effectiveness while maintaining analytical consistency.

Pharmaceutical customers prioritize system reliability, analytical quality, and integration with existing drug development infrastructure that enables coordinated protein analysis across multiple research types and development lines. The segment benefits from substantial pharmaceutical budgets and modernization programs that emphasize protein characterization tool acquisition for improved research quality and analytical efficiency.

Drug development modernization programs incorporate protein characterization systems as standard equipment for pharmaceutical research and compound analysis applications. At the same time, increasing regulatory standards are driving demand for analytical capabilities that maintain pharmaceutical requirements and minimize research errors.

Application dynamics include:

• Strong growth in pharmaceutical companies requiring comprehensive protein analysis assistance capabilities
• Increasing adoption in drug development facilities for high-precision analytical support applications
• Rising integration with pharmaceutical platforms for automated research scheduling and quality monitoring

What are the Drivers, Restraints, and Key Trends of the Protein Characterization and Identification Market?

Pharmaceutical innovation drives primary adoption as protein characterization systems provide analytical assistance capabilities that enable consistent research operations without manual dependency risks, supporting research decision-making and discovery missions that require precise protein analysis.

The demand for research modernization accelerates market expansion as pharmaceutical organizations seek effective analytical enhancement tools that minimize characterization errors while maintaining research effectiveness during complex drug development procedures and compound analysis scenarios. Research spending increases worldwide, creating sustained demand for protein characterization systems that complement traditional analytical equipment and provide operational flexibility in complex research environments.

Capital investment challenges vary across organizations regarding the deployment of protein characterization systems and research budget protocols, which may limit operational flexibility and market penetration in regions with constrained research budgets.

Technical performance limitations persist regarding system adaptability and integration complexity that may reduce effectiveness with legacy laboratory equipment, non-standardized analytical formats, or complex research workflows that limit characterization capabilities.

Market fragmentation across multiple research standards and analytical requirements creates compatibility concerns between different protein characterization system providers and existing laboratory infrastructure.

Adoption accelerates in pharmaceutical and biotechnology sectors where analytical precision justifies system costs, with geographic concentration in developed markets transitioning toward mainstream adoption in emerging economies driven by research modernization and analytical infrastructure development.

Technology development focuses on enhanced analytical precision, improved automation capabilities, and compatibility with diverse research systems that optimize analytical workflow and research effectiveness. The market could face disruption if alternative analytical technologies or budget restrictions significantly limit protein characterization deployment in pharmaceutical or biotechnology applications.

Analysis of the Protein Characterization and Identification Market by Key Country

The protein characterization and identification market demonstrates varied regional dynamics with Growth Leaders including United States (10.2% CAGR) and Germany (9.6% CAGR) driving expansion through research modernization and analytical infrastructure development.

Steady performers encompass Japan (9.2% CAGR), France (8.8% CAGR), and U.K. (8.4% CAGR), benefiting from established pharmaceutical industries and advanced analytical automation adoption. Emerging markets feature South Korea (8.0% CAGR), where specialized research applications and analytical technology integration support consistent growth patterns.

Country	CAGR (2025-2035)
United States	10.2%
Germany	9.6%
Japan	9.2%
France	8.8%
U.K.	8.4%
South Korea	8.0%

Regional synthesis reveals North American markets leading growth through research modernization and analytical infrastructure development, while European countries maintain strong expansion supported by pharmaceutical technology advancement and EU research standardization requirements. Asian markets show solid growth driven by biotechnology applications and analytical technology integration trends.

United States Drives Global Market Leadership

United States establishes market leadership through aggressive pharmaceutical research programs and comprehensive analytical infrastructure development, integrating advanced protein characterization systems as standard components in drug discovery operations and pharmaceutical research management. The country's 10.2% CAGR through 2035 reflects government initiatives promoting research innovation and domestic analytical capabilities that mandate advanced characterization systems in pharmaceutical installations. Growth concentrates in major research hubs, including Boston, San Francisco, and Research Triangle, where analytical technology development showcases integrated characterization systems that appeal to domestic pharmaceutical operators seeking advanced analytical capabilities and research enhancement applications.

American pharmaceutical technology providers are developing comprehensive protein characterization solutions that combine domestic production advantages with advanced features, including precision analytical algorithms and comprehensive research capabilities. Distribution channels through pharmaceutical procurement and analytical technology suppliers expand market access, while government funding for research technology development supports adoption across diverse pharmaceutical and biotechnology segments.

Strategic Market Indicators:

• Pharmaceutical systems leading adoption with 94% deployment rate in drug discovery and biotechnology analytical departments
• Government research programs providing substantial funding for domestic analytical automation development
• Local technology providers capturing 71% market share through competitive pricing and localized pharmaceutical support
• Biotechnology segment growth driven by pharmaceutical operator requirements for automated analytical systems
• Export market development for comprehensive protein characterization solutions targeting emerging research markets

Germany Emerges as European Research Leader

In major research centers including Berlin, Munich, and Frankfurt, pharmaceutical authorities and research operators are implementing advanced protein characterization systems as standard equipment for drug analysis and compound development applications, driven by increasing research spending and modernization programs that emphasize the use of automated analytical capabilities. The market is projected to demonstrate a 9.6% CAGR through 2035, supported by government research initiatives and analytical infrastructure development programs that promote the use of advanced characterization tools for pharmaceutical operators and research authorities. German pharmaceutical operators are adopting protein characterization systems that provide superior analytical capabilities and research enhancement features, particularly appealing in pharmaceutical regions where data quality represents critical research requirements.

Market expansion benefits from growing pharmaceutical technology capabilities and European technology development agreements that enable domestic advancement of advanced analytical systems for pharmaceutical and biotechnology applications. Technology adoption follows patterns established in research infrastructure, where analytical precision and regulatory compliance drive procurement decisions and system deployment.

Market Intelligence Brief:

• Pharmaceutical and biotechnology operator segments are driving initial adoption with 62% annual growth in protein characterization system procurement
• Research modernization programs emphasizing analytical tools for drug development and research quality
• Local pharmaceutical technology companies partnering with international providers for system development
• Pharmaceutical and biotechnology services implementing protein characterization for analytical assistance and research management

Japan Maintains Analytical Technology Excellence

Japan's advanced pharmaceutical technology market demonstrates sophisticated protein characterization deployment with documented analytical effectiveness in pharmaceutical departments and research centers through integration with existing research systems and analytical infrastructure. The country leverages engineering expertise in pharmaceutical technology and analytical systems integration to maintain a 9.2% CAGR through 2035. Research centers, including Tokyo, Osaka, and Kobe, showcase premium installations where protein characterization integrates with comprehensive pharmaceutical information systems and analytical platforms to optimize characterization accuracy and research workflow effectiveness.

Japanese pharmaceutical technology providers prioritize system reliability and national regulatory compliance in protein characterization development, creating demand for premium systems with advanced features, including analytical validation and integration with Japanese pharmaceutical standards. The market benefits from established pharmaceutical infrastructure and a willingness to invest in advanced analytical technologies that provide long-term research benefits and compliance with pharmaceutical regulations.

Market Intelligence Brief:

• Engineering focuses on Japanese pharmaceutical standards and system integration, driving premium research segment growth
• Pharmaceutical technology partnerships providing 46% faster analytical validation cycles
• Technology collaboration between Japanese pharmaceutical equipment manufacturers and international analytical companies
• Pharmaceutical training programs are expanding protein characterization integration in analytical management and research scenarios

Europe Market Split by Country

The Protein Characterization and Identification market in Europe is projected to grow from USD 5.2 billion in 2025 to USD 11.8 billion by 2035, registering a CAGR of 8.6% over the forecast period. Germany is expected to maintain its leadership position with a 28.2% market share in 2025, rising to 29.1% by 2035, supported by its advanced pharmaceutical technology sector and major research centers, including Berlin and Munich.

The United Kingdom follows with a 18.9% share in 2025, projected to reach 18.3% by 2035, driven by comprehensive pharmaceutical modernization programs and analytical technology development initiatives. France holds a 17.4% share in 2025, expected to increase to 18.6% by 2035 through specialized pharmaceutical applications and regulatory standardization requirements. Italy commands a 13.5% share in 2025, declining to 12.8% by 2035, while Spain accounts for 9.8% in 2025, increasing to 10.3% by 2035. The Nordic Countries region holds 7.9% in 2025, rising to 8.4% by 2035. BENELUX is anticipated to hold 3.8% in 2025, declining to 2.1% by 2035, while the Rest of Western Europe maintains a stable 0.5% declining to 0.4% share throughout the forecast period.

Mass Spectrometry Dominates Protein Characterization Demand in Japan

In Japan, the Protein Characterization and Identification market prioritizes Mass Spectrometry applications, which capture the dominant share of pharmaceutical facility and research laboratory installations due to their advanced features, including high-precision capabilities and seamless integration with existing research information technology infrastructure. Japanese research operators emphasize reliability, analytical accuracy, and long-term operational excellence, creating demand for mass spectrometry systems that provide comprehensive characterization capabilities and adaptive analytical control based on research requirements and pharmaceutical complexity scenarios. Chromatography applications maintain a secondary market position primarily in specialized applications and separation technology installations where analytical requirements meet research compliance without mass spectrometry dependency limitations.

Market Characteristics:

• Premium focus on mass spectrometry systems with advanced analytical algorithms and high-precision capabilities
• Integration requirements with existing research information systems and analytical management platforms
• Emphasis on analytical reliability and long-term performance in pharmaceutical applications

Pharmaceutical Companies Lead Protein Characterization Services in South Korea

In South Korea, the market structure favors pharmaceutical companies, which maintain dominant positions through comprehensive product portfolios and established research procurement networks supporting both pharmaceutical systems and biotechnology facilities. These providers offer integrated solutions combining advanced protein characterization systems with professional installation services and ongoing technical support that appeal to Korean research operators seeking reliable automated analytical systems. Local pharmaceutical technology contractors and system integrators capture moderate market share by providing localized service capabilities and competitive pricing for standard research installations. At the same time, domestic manufacturers focus on specialized applications and cost-effective solutions tailored to Korean pharmaceutical characteristics.

Channel Insights:

• Pharmaceutical companies maintaining premium market positioning through advanced analytical offerings
• Local research service networks expanding to support growing demand for professional installation and analytical support
• System integration capabilities are becoming a key differentiator for pharmaceutical and biotechnology applications

Competitive Landscape of the Protein Characterization and Identification Market

The Protein Characterization and Identification market operates with moderate concentration, featuring approximately 15-20 meaningful participants, where leading companies control roughly 58-63% of the global market share through established pharmaceutical technology relationships and comprehensive analytical portfolios. Competition emphasizes advanced analytical capabilities, system reliability, and integration with research platforms rather than price-based rivalry.

Market Leaders encompass Thermo Fisher Scientific, Agilent Technologies, Waters Corporation, Bruker Corporation, and Bio-Rad Laboratories, which maintain competitive advantages through extensive pharmaceutical technology expertise, global research contractor networks, and comprehensive system integration capabilities that create customer switching costs and support premium pricing. These companies leverage decades of analytical technology experience and ongoing research investments to develop advanced protein characterization systems with precision analytical algorithms and research validation features.

Technology Challengers include PerkinElmer Inc., Danaher Corporation, Shimadzu Corporation, SCIEX, and LECO Corporation, which compete through specialized pharmaceutical analytical focus and innovative research interfaces that appeal to pharmaceutical customers seeking advanced analytical capabilities and operational flexibility. These companies differentiate through rapid technology development cycles and specialized pharmaceutical application focus.

Regional Specialists feature companies that focus on specific geographic markets and specialized applications, including biotechnology research systems and integrated analytical platforms. Market dynamics favor participants that combine reliable analytical algorithms with advanced research software, including precision analytical control and automatic research monitoring capabilities. Competitive pressure intensifies as traditional pharmaceutical technology contractors expand into protein characterization systems. At the same time, specialized pharmaceutical companies challenge established players through innovative analytical solutions and cost-effective platforms targeting specialized research segments.

Key Players in the Protein Characterization and Identification Market

• Thermo Fisher Scientific
• Agilent Technologies
• Waters Corporation
• Bruker Corporation
• Bio-Rad Laboratories
• PerkinElmer Inc.
• Danaher Corporation
• Shimadzu Corporation
• SCIEX
• LECO Corporation

Scope of the Report

Item	Value
Quantitative Units	USD 18.5 Billion
Product	Instruments, Reagents, Software
Technology	Mass Spectrometry, Chromatography, Electrophoresis, Others
End User	Pharmaceutical Companies, Academic Research, Biotechnology
Regions Covered	North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Countries Covered	United States, Germany, Japan, France, U.K., South Korea, and 25+ additional countries
Key Companies Profiled	Thermo Fisher Scientific, Agilent Technologies, Waters Corporation, Bruker Corporation, Bio-Rad Laboratories, PerkinElmer Inc., Danaher Corporation, Shimadzu Corporation, SCIEX, LECO Corporation
Additional Attributes	Dollar sales by product and technology categories, regional adoption trends across North America, Europe, and Asia Pacific, competitive landscape with pharmaceutical technology providers and analytical specialists, research operator preferences for analytical precision and system reliability, integration with research information systems and analytical workflows, innovations in analytical algorithms and automated research management, and development of advanced solutions with enhanced precision and monitoring capabilities.

Protein Characterization and Identification Market by Segments

• Product :

  • Instruments
  • Reagents
  • Software

• Technology :

  • Mass Spectrometry
  • Chromatography
  • Electrophoresis
  • Others

• End User :

  • Pharmaceutical Companies
  • Academic Research
  • Biotechnology

• Region :

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Nordic Countries
    • BENELUX
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • ASEAN
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East & Africa
    • Kingdom of Saudi Arabia
    • Other GCC Countries
    • Turkey
    • South Africa
    • Other African Union
    • Rest of Middle East & Africa